Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease

Metastatic basal cell carcinoma may be treated with hedgehog pathway inhibitors, including vismodegib and sonidegib. However, patients can demonstrate resistance to these agents. We describe a man with metastatic basal cell carcinoma who did not respond well to vismodegib and sonidegib. Next generat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Cohen, Philip R., Kato, Shumei, Goodman, Aaron M., Ikeda, Sadakatsu, Kurzrock, Razelle
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5578053/
https://ncbi.nlm.nih.gov/pubmed/28788102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18081663
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados